... of the company's stock valued at $175,001,000 after purchasing an additional 3,095,804 shares in the last quarter. Ardsley Advisory Partners increased its holdings in TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners now ...
https://www.americanbankingnews.com/2018/05/16/therapeuticsmd-sees-unusually-large-options-volume-txmd.html
No comments:
Post a Comment